Encompass Health Corporation Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Encompass Health Corporation stock issued during period, value, stock options exercised for the quarter ending 2018-12-31 was $0.00.
- Encompass Health Corporation stock issued during period, value, stock options exercised for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Encompass Health Corporation stock issued during period, value, stock options exercised for the quarter ending 2017-09-30 was $700.00K, a 36.36% decline year-over-year.
- Encompass Health Corporation stock issued during period, value, stock options exercised for the quarter ending 2017-06-30 was $200.00K, a 33.33% decline year-over-year.
- Encompass Health Corporation stock issued during period, value, stock options exercised for fiscal 2020 was $1.10M, a 21.43% decline from fiscal 2019.
- Encompass Health Corporation stock issued during period, value, stock options exercised for fiscal 2019 was $1.40M, a 56.25% decline from fiscal 2018.
- Encompass Health Corporation stock issued during period, value, stock options exercised for fiscal 2018 was $3.20M, a 190.91% increase from fiscal 2017.
- Encompass Health Corporation stock issued during period, value, stock options exercised for fiscal 2017 was $1.10M, a 79.25% decline from fiscal 2016.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2020-12-31 | $1.10M 10-K · filed 2023-02-27 | |
| 2019-12-31 | $1.40M 10-K · filed 2022-02-25 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $3.20M 10-K · filed 2021-02-26 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $1.10M 10-K · filed 2020-02-27 |
| 2017-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $4.60M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $5.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $200.00K 10-Q · filed 2018-05-02 | $5.10M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $5.30M 10-K · filed 2019-02-27 |
| 2016-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $1.90M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | |
| 2016-03-31 | $400.00K 10-Q · filed 2017-04-28 | |
| 2015-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $2.30M 10-K · filed 2018-02-28 |
| 2014-12-31 | $7.40M 8-K · filed 2017-09-19 | |
| 2013-12-31 | $8.20M 10-K · filed 2014-02-20 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |